In the news: FTZ speculation, regulatory disputes and life sciences challenges

Shanghai's Free Trade Zone remains the focus of speculation, while a solution has been proposed for the standoff between US and Chinese regulators. Life sciences companies are having an increasingly tough time protecting their IP in China.

5 minute readSeptember 26, 2013 at 12:35 PM

clpstaff

& clp articles

Shanghai FTZ – speculation continues

This week theSouth China Morning Post reported that internet users in the Shanghai Free Trade Zone would be able to access websites blocked in the rest of China, such as

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)